In a position statement on cinacalcet use in children on dialysis, the authors emphasized avoiding hypocalcemia.
In a study, PTH exceeding 600 pg/mL prior to initiation of dialysis was associated with persistently high PTH in the first year of hemodialysis.
In a study, patients with severe secondary hyperparathyroidism appeared to benefit the most from surgery.
In a study of hemodialysis patients, hypercalcemia accompanied by high parathyroid hormone levels was associated with nearly 2.6-fold increased odds of intradialytic hypotension.
Thermal ablation and parathyroidectomy (PTx) both effectively treat secondary hyperparathyroidism (SHPT), according to research.
In a study, 5 of 9 hemodialysis patients undergoing total parathyroidectomy with autotransplantation experienced regression of tumoral calcinosis.
Prescriptions of drugs to treat chronic kidney disease-mineral bone disorders varies widely by country, but it is generally low, a study found.
A new meta-analysis found that cinacalcet plus vitamin D combination therapy and vitamin D monotherapy have similar effects on parathyroid hormone levels in dialysis patients with secondary hyperparathyroidism.
For patients on peritoneal dialysis, 1.75 vs 1.25 mmol/L dialysate calcium was superior at reducing intact parathyroid hormone levels, meta-analysis revealed.
In a small study, hungry bone syndrome developed in nearly 29% of patients despite receiving high-dose calcitriol prior to total parathyroidectomy with autotransplantation.